INSIGHT Clinical Trial: An Observational Study Assessing the Clinical Effectiveness of the VeriStrat® Test and Validating Immunotherapy Tests in Subjects with Non-Small Cell Lung Cancer
The purpose of this prospective, observational study is to collect information about how a physician uses the results of the VeriStrat® blood test to guide treatment decisions for patients with non-small cell lung cancer (NSCLC). Understanding how VeriStrat test results influence physician decisions and patient outcomes may help to better treat NSCLC in the future. This study will also look to establish whether new investigational tests can help better predict the effectiveness of certain medications for certain patients.
Helping Other Patients Excel (HOPE) Clinical Trial
HOPE is a friendly donor study designed to collect blood samples from patients with lung cancer for research purposes. Participation is voluntary, and your blood sample donation could help to discover blood-based tests that identify future patients who may benefit from targeted therapies. This is all done at no cost to patient, and Biodesix will arrange for the blood draw to be conducted from the comfort of a patient’s home.